International private equity firm Cinven, today announces that it has promoted Eugenio Preve to Partner with effect from 1 January 2020.
Eugenio is Head of the Milan office, a member of the Industrials sector team and leads the regional team for Italy. He has worked on a number of investments, including Amadeus, Avio, Eurovita and Medpace. He joined Cinven in 2009.
Cinven has significant experience in the Italian market both investing in Italian-headquartered businesses and on behalf of other portfolio companies that have operations in Italy. For example, Avio, the leading aerospace business, was a successful investment for Cinven having sold its two divisions to both GE and Leonardo-Finmeccanica ahead of listing on the Milan Stock Exchange, respectively.
Cinven is currently invested in Italian-headquartered Eurovita, the independent Italian life insurer that has completed a number of acquisitions in Italy. Other Cinven investments with considerable operations in Italy include Stada, the European manufacturer of prescription generics and over the counter products, and Synlab, a European market leader for laboratory diagnostics.
Commenting on this promotion, Stuart McAlpine, Managing Partner of Cinven Partners LLP, said:
“2019 was a busy year for Cinven, with the closing of our latest fund, the Seventh Cinven Fund at €10 billion. As we look forward to 2020 and the opportunities it presents, I am delighted to announce the promotion of Eugenio to Partner.
“Eugenio leads our Italian regional team and is a key member of our Industrials sector team. His promotion reflects his considerable hard work and commitment to both existing portfolio performance and deal origination.”
